期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 250, 期 1-2, 页码 59-65出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2012.06.001
关键词
Brain metastases; Cerebral oedema; Substance P; NK1 antagonist; Blood-brain barrier; Dexamethasone
资金
- Neurosurgical Research Foundation (Australia)
Dexamethasone, the standard treatment for peritumoral brain oedema, inhibits classical inflammation. Neurogenic inflammation, which acts via substance P (SP), has been implicated in vasogenic oedema in animal models of CNS injury. SP is elevated within and outside CNS tumours. This study investigated the efficacy of NK1 receptor antagonists, which block SP, compared with dexamethasone treatment, in a rat model of tumorigenesis. Dexamethasone reverted normal brain water content and reduced Evans blue and albumin extravasation, while NK1 antagonists did not ameliorate oedema formation. We conclude that classical inflammation rather than neurogenic inflammation drives peritumoral oedema in this brain tumour model. (c) 2012 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据